A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 3.27 EUR 2.19% Market Closed
Market Cap: 248.3m EUR
Have any thoughts about
Atrys Health SA?
Write Note

Atrys Health SA
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Atrys Health SA
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
A
Atrys Health SA
MAD:ATRY
Net Issuance of Common Stock
€554k
CAGR 3-Years
-75%
CAGR 5-Years
29%
CAGR 10-Years
N/A
No Stocks Found

Atrys Health SA
Glance View

Market Cap
248.3m EUR
Industry
Health Care

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

ATRY Intrinsic Value
5.33 EUR
Undervaluation 39%
Intrinsic Value
Price
A

See Also

What is Atrys Health SA's Net Issuance of Common Stock?
Net Issuance of Common Stock
554k EUR

Based on the financial report for Jun 30, 2024, Atrys Health SA's Net Issuance of Common Stock amounts to 554k EUR.

What is Atrys Health SA's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
29%

Over the last year, the Net Issuance of Common Stock growth was -95%. The average annual Net Issuance of Common Stock growth rates for Atrys Health SA have been -75% over the past three years , 29% over the past five years .

Back to Top